Literature DB >> 19929471

Indoleamine-2,3-dioxygenase enzyme expression and activity in polarized dendritic cells.

Benita Wolf1, David Posnick, Jan L Fisher, Lionel D Lewis, Marc S Ernstoff.   

Abstract

BACKGROUND AIMS: Polarized mature dendritic cells (DC) can activate cytolytic T-lymphocyte (CTL) responses and may be a more effective clinical strategy in DC-based cancer vaccines. A subset of mature DC can down-regulate the T-cell immune response through expression of indoleamine-2,3-dioxygenase (IDO). We determined whether polarizing DC ex vivo increased IDO expression and activity.
METHODS: Peripheral blood monocytes from healthy volunteers were cultured ex vivo in polarizing and non-polarizing culture conditions. DC IDO expression was detected by Western blot. IDO enzyme activity was determined by high-performance liquid chromatography (HPLC) measurement of kynurenine (K) and tryptophan (T) concentrations in culture supernatants.
RESULTS: IDO protein was markedly increased in DC after polarization (median 1222.4%, range 331.5-2113.3%) versus non-polarized DC (median 28.3%, range 3.7-119.8%; P=0.04). The median K/T ratio was significantly higher in polarized DC versus non-polarized DC (6.34, range 6.02-6.65, versus 0.047, range 0.004-0.541; P=0.04). IDO protein expression correlated with enzyme activity (r=0.80, P=0.002).
CONCLUSIONS: DC polarizing culture conditions increased expression of IDO protein and IDO enzyme activity. DC culture and maturation methodologies may impact the effectiveness of adoptive DC therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19929471      PMCID: PMC3786593          DOI: 10.3109/14653240903271230

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  16 in total

1.  Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division.

Authors:  Geon Kook Lee; Hyeon Jin Park; Megan Macleod; Phillip Chandler; David H Munn; Andrew L Mellor
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Simultaneous measurement of serum tryptophan and kynurenine by HPLC.

Authors:  B Widner; E R Werner; H Schennach; H Wachter; D Fuchs
Journal:  Clin Chem       Date:  1997-12       Impact factor: 8.327

3.  Polarized type-1 dendritic cells (DC1) producing high levels of IL-12 family members rescue patient TH1-type antimelanoma CD4+ T cell responses in vitro.

Authors:  Amy Wesa; Pawel Kalinski; John M Kirkwood; Tomohide Tatsumi; Walter J Storkus
Journal:  J Immunother       Date:  2007-01       Impact factor: 4.456

4.  Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression.

Authors:  Marion Wobser; Heike Voigt; Roland Houben; Andreas O Eggert; Matthias Freiwald; Ulrike Kaemmerer; Eckhart Kaempgen; David Schrama; Juergen C Becker
Journal:  Cancer Immunol Immunother       Date:  2006-12-29       Impact factor: 6.968

Review 5.  Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer.

Authors:  E Ranieri; M Gigante; W J Storkus; L Gesualdo
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

6.  A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation.

Authors:  Deborah Braun; Randy S Longman; Matthew L Albert
Journal:  Blood       Date:  2005-06-09       Impact factor: 22.113

7.  Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-gamma-inducible expression of human indoleamine 2,3-dioxygenase gene.

Authors:  S Y Chon; H H Hassanain; S L Gupta
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

8.  Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells.

Authors:  Katharina Gabriele Hüttner; Sabine Konstanze Breuer; Petra Paul; Otto Majdic; Andreas Heitger; Thomas Felzmann
Journal:  Cancer Immunol Immunother       Date:  2005-01       Impact factor: 6.968

9.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

Review 10.  Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism.

Authors:  M W Taylor; G S Feng
Journal:  FASEB J       Date:  1991-08       Impact factor: 5.191

View more
  4 in total

1.  Brugia malayi Microfilariae Induce Autophagy through an Interferon-γ Dependent Mechanism on Human Monocytes.

Authors:  Prakash Babu Narasimhan; Sameha Tariq; Leor Akabas; David W Dorward; Thomas B Nutman; Roshanak Semnani
Journal:  Am J Trop Med Hyg       Date:  2022-02-28       Impact factor: 2.345

Review 2.  Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor.

Authors:  Xiaotian Song; Qianqian Si; Rui Qi; Weidan Liu; Miao Li; Mengyue Guo; Lin Wei; Zhiyan Yao
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

3.  Tracking TRYCAT: A Critical Appraisal of Kynurenine Pathway Quantifications in Blood.

Authors:  Violette Coppens; Robert Verkerk; Manuel Morrens
Journal:  Front Pharmacol       Date:  2022-02-15       Impact factor: 5.810

4.  Dexamethasone and Monophosphoryl Lipid A Induce a Distinctive Profile on Monocyte-Derived Dendritic Cells through Transcriptional Modulation of Genes Associated With Essential Processes of the Immune Response.

Authors:  Paulina A García-González; Katina Schinnerling; Alejandro Sepúlveda-Gutiérrez; Jaxaira Maggi; Ahmed M Mehdi; Hendrik J Nel; Bárbara Pesce; Milton L Larrondo; Octavio Aravena; María C Molina; Diego Catalán; Ranjeny Thomas; Ricardo A Verdugo; Juan C Aguillón
Journal:  Front Immunol       Date:  2017-10-23       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.